Skip to content

Endothelial Cell Gene Networks of CVD

Endothelial Cell Gene Networks of CVD

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03529916
Enrollment
0
Registered
2018-05-18
Start date
2018-05-21
Completion date
2021-09-30
Last updated
2021-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Brief summary

The objective of this study is to identify relevant signature gene networks of cardiovascular disease in endothelial cells derived from circulating endothelial progenitor cells of individuals with established cardiovascular disease (CVD).

Detailed description

The investigators propose to enroll CVD and healthy subjects between 30 and 60 years of age, matched for age, gender, body mass index, and medication (statin and anti-hypertensive) use. Circulating endothelial progenitor cells will be isolated from blood and cultured in vitro to differentiate into endothelial cells.

Interventions

OTHERisolation of endothelial cells precursors in blood

Circulating endothelial precursor cells will be isolated and then cultured in vitro. RNA will be then isolated.

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Tufts University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

for CVD subjects:: • \>50% stenosis of one or more coronary arteries Inclusion Criteria for Healthy subjects: • absence of coronary artery stenosis

Exclusion criteria

for all subjects: * type 2 diabetes mellitus * chronic kidney disease, * other chronic diseases * dyslipidemia (fasting plasma LDL-C \>160 mg/dL and triglyceride levels \>150 mg/dL)

Design outcomes

Primary

MeasureTime frameDescription
Gene expression10 weeksGene expression \[ identify relevant signature gene networks of cardiovascular disease in endothelial cells\]

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026